Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis

Although the pan-genotypic direct-acting antiviral regimen was approved for treating chronic hepatitis C infection regardless of the hepatitis C virus (HCV) genotype, real-world data on its effectiveness against mixed-genotype or genotype-undetermined HCV infection are scarce. We evaluated the real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Hsu-Heng, Chen, Yang-Yuan, Lai, Jun-Hung, Chen, Hung-Ming, Yao, Chih-Ta, Huang, Siou-Ping, Liu, I-Ling, Zeng, Ya-Huei, Yang, Fang-Chi, Siao, Fu-Yuan, Chen, Mei-Wen, Su, Pei-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999637/
https://www.ncbi.nlm.nih.gov/pubmed/35407462
http://dx.doi.org/10.3390/jcm11071853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999637/
https://www.ncbi.nlm.nih.gov/pubmed/35407462
http://dx.doi.org/10.3390/jcm11071853

Ejemplares similares